scholarly journals Robotic bladder neck plication for incontinence treatment

2021 ◽  
Keyword(s):  
Bladder Neck

297: The Management and Outcome of Bladder Neck Strictures Associated with Sphincter Weakness after Radical Retropubic Prostatectomy

2006 ◽  
Vol 175 (4S) ◽  
pp. 99-99
Author(s):  
Daniela E. Andrich ◽  
James S. Taylor ◽  
Tamsin J. Greenwell ◽  
Anthony R. Mundy
Keyword(s):  
Bladder Neck ◽  
Radical Retropubic Prostatectomy ◽  
Retropubic Prostatectomy

157: The Vesicoprostatic Muscle: A Critical Landmark During Dissection of the Posterior Bladder Neck in Laparoscopic Radical Prostatectomy

2006 ◽  
Vol 175 (4S) ◽  
pp. 51-51 ◽  
Author(s):  
Fernando P. Secin ◽  
Nicholas T. Karanikolas ◽  
Anuradha Gopalan ◽  
Fernando J. Bianco ◽  
Bobby Shayegan ◽  
...  
Keyword(s):  
Radical Prostatectomy ◽  
Bladder Neck ◽  
Laparoscopic Radical Prostatectomy

675: Bladder Neck Sling for Treatment of Neurogenic Incontinence in Children: Long Term Follow-Up

2004 ◽  
Vol 171 (4S) ◽  
pp. 179-180
Author(s):  
Miguel Castellan ◽  
Rafael Gosalbez ◽  
Andrew Labbie ◽  
Michael DiSandro ◽  
Emad Ibrahim
Keyword(s):  
Bladder Neck ◽  
Long Term Follow Up

The Transverse Bladder Neck Repair

2001 ◽  
Vol 9 (1) ◽  
pp. 37-45
Author(s):  
J. Chadwick Plaire ◽  
Michael E. Mitchell
Keyword(s):  
Bladder Neck

Bladder Neck Sphincteroplasty: The Cinch Procedure

2001 ◽  
Vol 9 (1) ◽  
pp. 31-36 ◽  
Author(s):  
Moneer K. Hanna
Keyword(s):  
Bladder Neck

Clinical and Radiological Changes after use of Alpha-1 Blocker Therapy in Patients of Posterior Urethral Valve with Bladder Neck Hypertrophy

JMS SKIMS ◽  
2009 ◽  
Vol 12 (1) ◽  
pp. 3-7
Author(s):  
Aejaz A Baba ◽  
Bajpai Minu
Keyword(s):  
Bladder Neck ◽  
Posterior Urethral Valve ◽  
Posterior Urethral Valves ◽  
Blocker Therapy ◽  
Urethral Valve ◽  
Novel Method ◽  
Radiological Changes ◽  
Group 2 ◽  
Mean Time ◽  
Group 1

Background: We evaluated the effects of alpha-1 blocker therapy on clinical and radiological abnormalities in patients of posterior urethral valve with bladder neck hypertrophy. Materials and Methods: A total of 74 patients with posterior urethral valves were seen at our department between 2003 and 2007. Out of these 24 had radiological evidence of bladder neck hypertrophy. Those patients with bladder neck hypertrophy who were seen before June 2006 and did not receive alpha-1 blocker (prazocin) therapy after valve ablation were assigned to group 1 (n=10). Group 2 consisted of 14 age matched patients with bladder neck hypertrophy and comparable prognostic factors who received alpha-1 blocker therapy after valve ablation (n=14). Micturating cystourethrography (MCU) was done periodically and a novel method used to calculate bladder neck hypertrophy. Trends in symptoms and radiological changes were evaluated throughout follow-up. Results: Mean patient age at presentation was 3.02±2.68 years in group 1 and 3.12±3.4 years in group 2. Bladder neck hypertrophy decreased from 2.3±1.0 to 2.0±0.5 in a mean time of 52.0 (34-52) weeks in group 1 where as it decreased from 2.2±0.5 to 1.6±0.3 in a mean time of 32.0 (22-52) weeks. Symptomatically patients in group 2 who received alpha-1 blocker therapy after valve ablation were better and had quick resolution of bladder neck hypertrophy. Conclusions: Use of alpha-1 blocker therapy in patients of posterior urethral valve with bladder neck hypertrophy helps in quick resolution of bladder neck hypertrophy. J Med Sci 2009;12(1):3-7.

Sign in / Sign up

Export Citation Format

Share Document